JHS · JHS Svendgaard Laboratories Limited · Financials
Volume · Nov 13
1693
Avg daily vol (14 sessions)
4054
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.
Revenue
1.02B
+10.5%
FY2026
Net Income
-19.22M
+90.3%
FY2026
Operating Cash Flow
-26.58M
+48.7%
FY2026
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2018 |
|---|---|---|---|---|---|---|---|---|---|
| INR | 1.08B | 1.02B | 919.97M | 707.98M | 962.07M | 862.52M | 1.01B | 1.39B | 1.43B |
| INR | 74.03M | 74.96M | 79.5M | 63.46M | 74.65M | 70.52M | 72.55M | 87.61M | 68.13M |
| INR | 11.09M | 8.59M | 5.65M | 4.6M | 10.42M | 13.94M | 12.4M | 19.53M | 7.38M |
| INR | -32.41M | -22.91M | -125.08M | -34.29M | -218.4M | 1.03M | 9.68M | -58.43M | 384.24M |
| INR | -20.58M | -3.68M | 71.88M | 6.29M | -50.65M | 43.92M | 9.4M | -7.24M | 123.69M |
| INR | -11.83M | -19.22M | -197.44M | -40.58M | -154.64M | -40.52M | 11.98M | -19.79M | 261.49M |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2022–FY2026: 0 in dividends.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.